MET and lung cancer: Overall, the Ion AmpliSeq Colon and Lung Cancer Research Panel v2, improved with three additional amplicons to cover exon 14 and its surrounding introns, enabled an increased detection rate of MET exon 14 skipping molecular alterations [27].